VEGF/VEGFR signalling as a target for inhibiting angiogenesis.
about
Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasisDietary compound isoliquiritigenin inhibits breast cancer neoangiogenesis via VEGF/VEGFR-2 signaling pathwayThe proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1.MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells.Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cellsNew insights in synovial angiogenesis.Angiogenesis in rheumatoid arthritis.Angiogenesis and its targeting in rheumatoid arthritisHIF-VEGF pathways are critical for chronic otitis media in Junbo and Jeff mouse mutants.Targeting Angiogenesis in Rheumatoid ArthritisIndirubin derivative E804 inhibits angiogenesis.Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.The Histone Methyltransferase Inhibitor BIX01294 Inhibits HIF-1α Stability and Angiogenesis.Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells.Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.A high-affinity human/mouse cross-reactive monoclonal antibody, specific for VEGFR-2 linear and conformational epitopes.Gene regulatory network inference: evaluation and application to ovarian cancer allows the prioritization of drug targets.PKN3 is the major regulator of angiogenesis and tumor metastasis in miceEndogenous ribosomal protein L29 (RPL29): a newly identified regulator of angiogenesis in miceTumor vessel-injuring ability improves antitumor effect of cytotoxic T lymphocytes in adoptive immunotherapysMEK1 inhibits endothelial cell proliferation by attenuating VEGFR-2-dependent-Akt/eNOS/HIF-1α signaling pathways.Molecular imaging probes for diagnosis and therapy evaluation of breast cancerTubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft modelA novel polysaccharide from Sargassum integerrimum induces apoptosis in A549 cells and prevents angiogensis in vitro and in vivoDiscovering small molecule ligands of vascular endothelial growth factor that block VEGF-KDR binding using label-free microarray-based assays.Emerging drugs for targeted therapy of bladder cancer.Peroxisome proliferator-activated receptor-gamma ligands as investigational modulators of angiogenesis.YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models.Peroxisome Proliferator-Activated Receptor-gamma Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in Cancer.Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention.Evolving strategies: future treatment of glioblastoma.Emerging therapies for the treatment of neovascular age related macular degeneration.Investigational VEGF antagonists for psoriasis.Novel investigational vascular endothelial growth factor (VEGF) receptor antagonists for psoriasis.SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.Inhibition of angiogenesis as a new therapeutic target in the treatment of lepromatous leprosy.Vascular endothelial growth factor receptor-1 (VEGFR-1) expression in human corneal fibroblast decreased with age.Generation and characterization of a novel human IgG1 antibody against vascular endothelial growth factor receptor 2.Incisor degeneration in rats induced by vascular endothelial growth factor/fibroblast growth factor receptor tyrosine kinase inhibition.Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer.
P2860
Q22305863-BFAAC1E2-3C38-4D21-B248-65F48AA1B293Q28385231-EF871EC7-B111-410D-BEC5-222D5843D350Q33614283-8DFA75B8-B347-4832-80E3-F6DC1C2C1BBFQ33938788-1A25C2B5-191C-4E59-A45E-548C770E662AQ34011505-4C80A637-C83C-4EBF-ABD2-1B951005040AQ34022062-F4C7925A-9D94-4339-8BB8-C061E76BA86BQ34051829-583E076A-7FE8-472D-8712-F5B97A166D09Q34051950-777C9770-EE7E-48D6-A787-5ED023DB51AFQ34058200-C024DE06-E765-43B0-9865-57849367DC81Q34058895-550E6651-F731-4C6A-BA56-AEE1F19600C5Q34254864-51EC1FAD-D7EE-4292-B81D-43322464C3D8Q35532669-E85B6430-A582-4FCD-B285-231F905F4F08Q35749723-81A330D9-E351-47ED-896A-01C4AA983C26Q35776368-5AE0549C-27A9-40CF-8133-77CA7173C0D7Q35783198-1F44050E-3DB2-450A-A5FB-B4774F5EB709Q35828124-EA22486F-2286-4797-9EFD-D1B27A9589F1Q36424741-0997AE17-1EA6-4845-B463-AF97821616FAQ36442867-30D0A616-56D0-44CF-BC00-DACC909D3B7AQ36486025-56B3DA39-C420-4E4B-8AF8-00F356893E47Q36499639-39898B0C-41B6-40DF-BCFC-7EA0B8835511Q36544702-FEFBE0F5-634E-4BE8-891E-502ACDE7FB55Q36692448-C18A4405-73B5-465A-B747-C89AAEF11135Q36905630-4917B241-0D5D-40ED-B401-082F75CFC560Q36928661-88459F1F-7706-4941-8F21-7D20DF64A0EBQ36936860-45143677-1042-43BF-A553-EB3B98E006D1Q36944022-8208E2D2-6BE4-4188-A4A7-C80035E6B840Q36964693-40D18AAA-7BC7-4041-95DB-539DA1E8DEFCQ37122693-7886C880-321C-4EE6-97D0-E39CE9E6634AQ37157524-25B5989D-AC71-402A-92EB-3AF42F87BDAEQ37395327-F7984574-6C69-400F-9EB3-A509B4296612Q37862235-4D3CC217-4CEB-43BC-93B7-B01C577ABBF6Q37879168-5BB7CF4A-9955-4296-BBA4-B7D91A92D819Q37956733-6FD9A63D-B788-4507-B957-0114D5B4572DQ38728552-4E36E246-18AB-4712-9570-688B006F7E34Q39521060-B7608CA9-5B84-4C28-988E-C17D0BF60EBFQ40699468-975EB143-91D0-4676-9820-5DA63B3AECA2Q42173109-655F6E90-F42F-4294-861D-27DF7CFAAA85Q42801724-F726D811-7BED-4A87-9DEE-7559F928D283Q43184381-0C453444-EE52-433B-8BCF-A315ED8EF444Q44645655-6937A6D0-5AD7-48C2-98F0-26FBCE2DEC07
P2860
VEGF/VEGFR signalling as a target for inhibiting angiogenesis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
VEGF/VEGFR signalling as a target for inhibiting angiogenesis.
@ast
VEGF/VEGFR signalling as a target for inhibiting angiogenesis.
@en
type
label
VEGF/VEGFR signalling as a target for inhibiting angiogenesis.
@ast
VEGF/VEGFR signalling as a target for inhibiting angiogenesis.
@en
prefLabel
VEGF/VEGFR signalling as a target for inhibiting angiogenesis.
@ast
VEGF/VEGFR signalling as a target for inhibiting angiogenesis.
@en
P2093
P2860
P356
P1476
VEGF/VEGFR signalling as a target for inhibiting angiogenesis.
@en
P2093
Alex Kiselyov
Konstantin V Balakin
Sergey E Tkachenko
P2860
P304
P356
10.1517/13543784.16.1.83
P407
P577
2007-01-01T00:00:00Z